Standardized Chemical Allergen [EPC]

30 marketed 1 in Phase 2

This page covers all Standardized Chemical Allergen [EPC] drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Amyloid beta A4 protein, Soluble guanylate cyclase, Sodium channel protein type 5 subunit alpha.

Targets

Amyloid beta A4 protein · Soluble guanylate cyclase · Sodium channel protein type 5 subunit alpha · Arachidonate 5-lipoxygenase, Prostaglandin G/H synthase 1 · Sodium channel alpha subunits; brain (Types I, II, III) · Alpha-2A adrenergic receptor · Sodium/nucleoside cotransporter 1, 5-hydroxytryptamine receptor 6, Adenosine receptor A3 · Proteasome subunit beta type-8 · NAD-dependent protein deacetylase sirtuin-2 · Not specified

Marketed (30)

Phase 2 pipeline (1)

Patent intelligence